HK1170183A1 - 腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途 - Google Patents

腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途

Info

Publication number
HK1170183A1
HK1170183A1 HK12111031.4A HK12111031A HK1170183A1 HK 1170183 A1 HK1170183 A1 HK 1170183A1 HK 12111031 A HK12111031 A HK 12111031A HK 1170183 A1 HK1170183 A1 HK 1170183A1
Authority
HK
Hong Kong
Prior art keywords
enterococcal
prophylaxis
pathogens
therapy
vaccine component
Prior art date
Application number
HK12111031.4A
Other languages
English (en)
Inventor
Johannes Hbner
Elizabeth Grohmann
Andrea Kropec-Hbner
Original Assignee
Univ Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg filed Critical Univ Freiburg
Publication of HK1170183A1 publication Critical patent/HK1170183A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12111031.4A 2010-11-05 2012-11-02 腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途 HK1170183A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10190167.6A EP2450053B1 (en) 2010-11-05 2010-11-05 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis

Publications (1)

Publication Number Publication Date
HK1170183A1 true HK1170183A1 (zh) 2013-02-22

Family

ID=43528337

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111031.4A HK1170183A1 (zh) 2010-11-05 2012-11-02 腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途

Country Status (6)

Country Link
US (1) US20130309264A1 (zh)
EP (1) EP2450053B1 (zh)
JP (1) JP6338375B2 (zh)
CA (1) CA2816913A1 (zh)
HK (1) HK1170183A1 (zh)
WO (1) WO2012059556A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3415160B1 (en) 2014-03-04 2021-08-18 Klinikum der Universität München Polypeptides derived from enterococcus and their use for vaccination and the generation of therapeutic antibodies
RU2705415C1 (ru) * 2019-01-10 2019-11-07 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ диагностики стафилококковой абдоминальной хирургической инфекции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401689D0 (en) * 1994-01-28 1994-03-23 Univ Manchester Diagnosis and treatment of endocarditis
JPH07238024A (ja) * 1994-02-25 1995-09-12 Nichinichi Seiyaku Kk 好中球機能改善剤
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
US20050026218A1 (en) 2003-05-30 2005-02-03 Agencourt Bioscience Corporation Protein interaction mapping
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤

Also Published As

Publication number Publication date
JP6338375B2 (ja) 2018-06-06
US20130309264A1 (en) 2013-11-21
JP2014505016A (ja) 2014-02-27
CA2816913A1 (en) 2012-05-10
EP2450053B1 (en) 2016-06-15
WO2012059556A1 (en) 2012-05-10
EP2450053A1 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
EP2536425A4 (en) VACCINES FOR USE IN PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUS DISEASE
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
SI2627334T1 (sl) Sestavki za uporabo pri zdravljenju virusnih infekcij
EP3049104A4 (en) VACCINATE COMPOSITIONS AND ADJUVANCES AND METHODS OF TREATING ANTICIPATED DISEASES OF HARM
IN2014CN03555A (zh)
GB2503066B8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
ZA201408056B (en) Compositions and methods for the treatment of mucositis
EP2651439A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HUMAN ADENOVIRUS 36 INFECTION
SG10201503450WA (en) Vaccine against beta-herpesvirus infection and use thereof
EP2825196A4 (en) ADJUVANT AND VACCINE COMPOSITIONS
HRP20181879T1 (hr) Spojevi za liječenje pretilosti i postupci za njihovu upotrebu
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
EP2753363A4 (en) MG53 COMPOSITIONS AND METHOD FOR THE TREATMENT AND PREVENTION OF RESPIRATORY INFLUENZES
HK1204545A1 (zh) 用於治療骨空隙和開放性骨折的組合物和方法
HK1208680A1 (zh) 治療和預防呼吸道合胞體病毒感染的新吲唑類化合物
EP2678361A4 (en) COMPOSITIONS WITH IMPROVED IMMUNOGENICITY AND / OR REDUCED REACTIVITY AND METHOD OF USE THEREOF
EP2522360A4 (en) VACCINE FOR TAUTOPATHY TREATMENT
EP2549867A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF INJURIES
EP2934578A4 (en) VACCINES FOR TREATING CANCER AND COMPOSITIONS FOR IMPROVING VACCINE EFFICIENCY
HK1175786A1 (zh) 合成的 模擬物及其作為用於治療和/或預防革蘭氏陽性菌感染的疫苗成分的用途
HK1170183A1 (zh) 腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途
EP2793875A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF A DIVERTICULOSE
ZA201308025B (en) The use of secnidazole in treating dental infections

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221107